Does adjuvant vitespen prevent recurrence in patients with locally advanced kidney cancer?
Doehn
Christian
C
Department of Urology, University of Lübeck Medical School, Lübeck, Germany. doehn@medinf.mu-luebeck.de
Jocham
Dieter
D